These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 12743622)
21. Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (inmunoferón). Prieto A; Reyes E; Bernstein ED; Martinez B; Monserrat J; Izquierdo JL; Callol L; de LUCAS P; Alvarez-Sala R; Alvarez-Sala JL; Villarrubia VG; Alvarez-Mon M Am J Respir Crit Care Med; 2001 Jun; 163(7):1578-83. PubMed ID: 11401877 [TBL] [Abstract][Full Text] [Related]
22. Hepatic and central nervous system cytochrome P450 are down-regulated during lipopolysaccharide-evoked localized inflammation in brain. Renton KW; Nicholson TE J Pharmacol Exp Ther; 2000 Aug; 294(2):524-30. PubMed ID: 10900228 [TBL] [Abstract][Full Text] [Related]
23. Alterations in hepatic phase I and phase II biotransformation enzymes by garlic oil in rats. Dalvi RR Toxicol Lett; 1992 May; 60(3):299-305. PubMed ID: 1595088 [TBL] [Abstract][Full Text] [Related]
24. Kupffer cell-mediated differential down-regulation of cytochrome P450 metabolism in rat hepatocytes. Milosevic N; Schawalder H; Maier P Eur J Pharmacol; 1999 Feb; 368(1):75-87. PubMed ID: 10096772 [TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism. Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899 [TBL] [Abstract][Full Text] [Related]
26. Bacterial lipopolysaccharide enhances aflatoxin B1 hepatotoxicity in rats by a mechanism that depends on tumor necrosis factor alpha. Barton CC; Barton EX; Ganey PE; Kunkel SL; Roth RA Hepatology; 2001 Jan; 33(1):66-73. PubMed ID: 11124822 [TBL] [Abstract][Full Text] [Related]
27. Effect of bisphenol A on drug metabolising enzymes in rat hepatic microsomes and precision-cut rat liver slices. Pfeiffer E; Metzler M Arch Toxicol; 2004 Jul; 78(7):369-77. PubMed ID: 15114436 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic effect of propolis and paclitaxel on hepatic phase I and II enzymes and marker enzymes in dimethylbenz(a)anthracene-induced breast cancer in female rats. Padmavathi R; Senthilnathan P; Sakthisekaran D Comp Biochem Physiol C Toxicol Pharmacol; 2006 Jul; 143(3):349-54. PubMed ID: 16720105 [TBL] [Abstract][Full Text] [Related]
29. Down-regulation of cytochrome P450 proteins and its activities by Shiga-like toxin II from Escherichia coli O157:H7. Kitaichi K; Nakayama H; Ueyama J; Nadai M; Baba K; Takagi K; Takagi K; Ohta M; Hasegawa T Biochem Pharmacol; 2004 Apr; 67(8):1427-35. PubMed ID: 15041460 [TBL] [Abstract][Full Text] [Related]
30. Differential modulation of xenobiotic metabolizing enzymes by vanadium during diethylnitrosamine-induced hepatocarcinogenesis in Sprague-Dawley rats. Chakraborty A; Selvaraj S Neoplasma; 2000; 47(2):81-9. PubMed ID: 10985472 [TBL] [Abstract][Full Text] [Related]
31. Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues. Nannelli A; Messina A; Marini S; Trasciatti S; Longo V; Gervasi PG Arch Toxicol; 2007 Jul; 81(7):479-87. PubMed ID: 17364183 [TBL] [Abstract][Full Text] [Related]
32. Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat. Chen YL; Florentin I; Batt AM; Ferrari L; Giroud JP; Chauvelot-Moachon L Biochem Pharmacol; 1992 Jul; 44(1):137-48. PubMed ID: 1632828 [TBL] [Abstract][Full Text] [Related]
33. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Khatsenko OG; Gross SS; Rifkind AB; Vane JR Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11147-51. PubMed ID: 7504296 [TBL] [Abstract][Full Text] [Related]
34. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes. Ahn D; Putt D; Kresty L; Stoner GD; Fromm D; Hollenberg PF Carcinogenesis; 1996 Apr; 17(4):821-8. PubMed ID: 8625497 [TBL] [Abstract][Full Text] [Related]
35. Altered enzyme activities of xenobiotic biotransformation in kidneys after subchronic administration of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) to rats. Heiskanen K; Linström-Seppä P; Haataja L; Vaittinen SL; Vartiainen T; Komulainen H Toxicology; 1995 Jun; 100(1-3):121-8. PubMed ID: 7624869 [TBL] [Abstract][Full Text] [Related]
36. Changes in hepatic phase I and phase II biotransformation enzyme expression and glutathione levels following atrazine exposure in female rats. Zimmerman AD; Breckenridge CB; Yi KD; Sawhney Coder P; Wanders D; Judd RL; Foradori CD Xenobiotica; 2018 Sep; 48(9):867-881. PubMed ID: 28882082 [TBL] [Abstract][Full Text] [Related]
37. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention. Buetler TM; Bammler TK; Hayes JD; Eaton DL Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305 [TBL] [Abstract][Full Text] [Related]
38. Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450. Sewer MB; Koop DR; Morgan ET Drug Metab Dispos; 1996 Apr; 24(4):401-7. PubMed ID: 8801054 [TBL] [Abstract][Full Text] [Related]
39. The signal transduction pathways involved in hepatic cytochrome P450 regulation in the rat during a lipopolysaccharide-induced model of central nervous system inflammation. Abdulla D; Goralski KB; Del Busto Cano EG; Renton KW Drug Metab Dispos; 2005 Oct; 33(10):1521-31. PubMed ID: 16006567 [TBL] [Abstract][Full Text] [Related]
40. Endogenous production of tumor necrosis factor in normal mice orally treated with Deodan--a preparation from Lactobacillus bulgaricus "LB51". Davidkova G; Popova P; Guencheva G; Bogdanov A; Pacelli E; Auteri A; Mincheva V Int J Immunopharmacol; 1992 Nov; 14(8):1355-62. PubMed ID: 1464468 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]